A Billion Here ... A Billion There
Yesterday, The Freedonia Group issued a press release stating that the health care market for nanotechnology related products will be $6.5 billion by 2009. If this sounds a little familiar perhaps it is because last month another organization released a similar press release explaining that nanotechnology will account for only $1.7 billion in nano-related health products by 2009.
Who are you to believe?
As I explained in my March 21 post which you can read here, I listed all the reasons why I felt $1.7 billion was too low. Freedonia's figures may be closer to the mark but I would urge my readers to think twice before shilling out $4,200 for the report.
The fact is that the field is moving so fast and so many of the big drug companies are now involved in nanotechnology that almost anything happen. Furthermore, regulatory issues are almost certain to play a larger and more integral role in the development field -- and, as most people know, the regulatory process is incredibly difficult to predict.
To be fair, I have not--and don't intend to--purchase Freedonia's Report but my gut instinct tells me that you can get almost all of the same information from my favorite nanotechnology news source: Nanotechnology Now. Bottom-line: Save your money and just keep doing your own due diligence.
Related Links:
Starpharma "Nano" star on the rise?
Elan Good News for Nanotech Investors?
pSivida: Down Under Comapny has Big Upside Potential
Who are you to believe?
As I explained in my March 21 post which you can read here, I listed all the reasons why I felt $1.7 billion was too low. Freedonia's figures may be closer to the mark but I would urge my readers to think twice before shilling out $4,200 for the report.
The fact is that the field is moving so fast and so many of the big drug companies are now involved in nanotechnology that almost anything happen. Furthermore, regulatory issues are almost certain to play a larger and more integral role in the development field -- and, as most people know, the regulatory process is incredibly difficult to predict.
To be fair, I have not--and don't intend to--purchase Freedonia's Report but my gut instinct tells me that you can get almost all of the same information from my favorite nanotechnology news source: Nanotechnology Now. Bottom-line: Save your money and just keep doing your own due diligence.
Related Links:
Starpharma "Nano" star on the rise?
Elan Good News for Nanotech Investors?
pSivida: Down Under Comapny has Big Upside Potential
posted by Jack at 4:23 PM
